Literature DB >> 15241502

[Adult-onset primary immunodeficiencies].

S Gadola1, U Salzer, H Schultz, B Grimbacher.   

Abstract

Different individuals with the same kind of primary immunodeficiency may start having symptoms from early childhood on, or alternatively much later in adult life, or never. The differences in phenotype can only partly be deduced from genotype-analysis or--in case of female patients with X-linked diseases--from age-related skewing of lyonisation. The role of compensatory immune mechanisms is less clear. The microbial spectrum of infections is usually the same for both adult and infantile forms of a special primary immunodeficiency syndrome. Yet, many of the adult forms are associated with non-infectious complications, such as granuloma formation, autoimmunity or tumors. Besides standard antibiotic treatment and IgG replacement therapy, there are now different cytokine- or enzyme-replacement regimens available for some of the primary immunodeficiencies. However, exact diagnostic classification of the immunodeficiency should be obtained before such treatment modalities are used. Adult primary immunodeficiency syndromes therefore represent a challenge to both clinicians and molecular biologists.

Entities:  

Mesh:

Year:  2004        PMID: 15241502     DOI: 10.1007/s00108-004-1230-7

Source DB:  PubMed          Journal:  Internist (Berl)        ISSN: 0020-9554            Impact factor:   0.743


  43 in total

Review 1.  Selective IgA deficiency (SIgAD) and common variable immunodeficiency (CVID).

Authors:  L Hammarström; I Vorechovsky; D Webster
Journal:  Clin Exp Immunol       Date:  2000-05       Impact factor: 4.330

Review 2.  Molecular basis of IgG subclass deficiency.

Authors:  Q Pan; L Hammarström
Journal:  Immunol Rev       Date:  2000-12       Impact factor: 12.988

Review 3.  TAP deficiency syndrome.

Authors:  S D Gadola; H T Moins-Teisserenc; J Trowsdale; W L Gross; V Cerundolo
Journal:  Clin Exp Immunol       Date:  2000-08       Impact factor: 4.330

Review 4.  IgA deficiency.

Authors:  P D Burrows; M D Cooper
Journal:  Adv Immunol       Date:  1997       Impact factor: 3.543

5.  Adenosine deaminase deficiency in adults.

Authors:  H Ozsahin; F X Arredondo-Vega; I Santisteban; H Fuhrer; P Tuchschmid; W Jochum; A Aguzzi; H M Lederman; A Fleischman; J A Winkelstein; R A Seger; M S Hershfield
Journal:  Blood       Date:  1997-04-15       Impact factor: 22.113

6.  Mutations in the mu heavy-chain gene in patients with agammaglobulinemia.

Authors:  L Yel; Y Minegishi; E Coustan-Smith; R H Buckley; H Trübel; L M Pachman; G R Kitchingman; D Campana; J Rohrer; M E Conley
Journal:  N Engl J Med       Date:  1996-11-14       Impact factor: 91.245

7.  Clinical and molecular analysis of patients with defects in micro heavy chain gene.

Authors:  Eduardo Lopez Granados; Andrea S Porpiglia; Mary Beth Hogan; Nuria Matamoros; Silvia Krasovec; Claudio Pignata; C I E Smith; Lennart Hammarstrom; Janne Bjorkander; Bernd H Belohradsky; G Fontan Casariego; M C Garcia Rodriguez; Mary Ellen Conley
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

Review 8.  Common variable immunodeficiency.

Authors:  C Cunningham-Rundles
Journal:  Curr Allergy Asthma Rep       Date:  2001-09       Impact factor: 4.806

9.  Gastrointestinal pathology in patients with common variable immunodeficiency and X-linked agammaglobulinemia.

Authors:  K Washington; T T Stenzel; R H Buckley; M R Gottfried
Journal:  Am J Surg Pathol       Date:  1996-10       Impact factor: 6.394

10.  Chronic granulomatous disease in adults.

Authors:  J G Liese; V Jendrossek; A Jansson; T Petropoulou; S Kloos; M Gahr; B H Belohradsky
Journal:  Lancet       Date:  1996-01-27       Impact factor: 79.321

View more
  3 in total

1.  Primary immune deficiencies presenting in adults: seven years of experience from Iran.

Authors:  Davood Mansouri; Parisa Adimi; Mehdi Mirsaedi; Nahal Mansouri; Payam Tabarsi; Majid Amiri; Hamid R Jamaati; Masoud Motavasseli; Noushin Baghaii; Ali Cheraghvandi; Reza Rouhi; Navid A Roozbahany; Soheila Zahirifard; Forouzan Mohammadi; Mohammad R Masjedi; Ali A Velayati; Jean L Casanova; David P Speert; R Kevin Elwood; Robert Schellenberg; Stuart E Turvey
Journal:  J Clin Immunol       Date:  2005-07       Impact factor: 8.317

Review 2.  [Immunoglobulins in primary antibody deficiency: should they also be used in sepsis and other indications?].

Authors:  S Kluge; G de Heer; A Nierhaus; G Kreymann
Journal:  Internist (Berl)       Date:  2007-11       Impact factor: 0.743

3.  Late-Onset Antibody Deficiency Due to Monoallelic Alterations in NFKB1.

Authors:  Claudia Schröder; Georgios Sogkas; Manfred Fliegauf; Thilo Dörk; Di Liu; Leif G Hanitsch; Sophie Steiner; Carmen Scheibenbogen; Roland Jacobs; Bodo Grimbacher; Reinhold E Schmidt; Faranaz Atschekzei
Journal:  Front Immunol       Date:  2019-11-14       Impact factor: 7.561

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.